Biotech News

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

Materialise (MTLS)Materialise2026-06-25 13:46 ESTEarnings

LEUVEN, Belgium --(BUSINESS WIRE)--Apr. 23, 2026-- Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the first quarter ended

Open original release

Related news

Materialise

Materialise is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States